Gene · 2248
Papers2,103
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 2,103
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fibroblast Subsets in Intestinal Homeostasis, Carcinogenesis, Tumor Progression, and Metastasis. | Cancers (Basel) | 2021 | 33430285 | PubTator, text mining | PubMed |
| Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions. | Prostate Cancer Prostatic Dis | 2021 | 33420417 | PubTator, text mining | PubMed |
| Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma. | Cancer Cell | 2021 | 33417831 | PubTator, text mining | PubMed |
| An integrated multi-omics approach to identify regulatory mechanisms in cancer metastatic processes. | Genome Biol | 2021 | 33413550 | PubTator, text mining | PubMed |
| Contemporary Molecular Classification of Urinary Bladder Cancer. | In Vivo | 2021 | 33402452 | PubTator, text mining | PubMed |
| A Retrospective Study and Literature Review of Cervical Villoglandular Adenocarcinoma: A Candidate Paradigm of Silva System Pattern A. | Appl Immunohistochem Mol Morphol | 2021 | 33337634 | PubTator, text mining | PubMed |
| Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors. | Oncologist | 2021 | 33325566 | PubTator, text mining | PubMed |
| An insight into the interaction between α-ketoamide- based inhibitor and coronavirus main protease: A detailed in silico study. | Biophys Chem | 2021 | 33285430 | PubTator, text mining | PubMed |
| A Phase II Study of Telisotuzumab Vedotin in Patients With c-MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753). | Clin Lung Cancer | 2021 | 33221175 | PubTator, text mining | PubMed |
| ESR1 genetic alterations and their association with clinicopathologic characteristics in advanced breast cancer: a single academic institution experience. | Hum Pathol | 2021 | 33157125 | PubTator, text mining | PubMed |
| Genotyping of Cerebrospinal Fluid Associated With Osimertinib Response and Resistance for Leptomeningeal Metastases in EGFR-Mutated NSCLC. | J Thorac Oncol | 2021 | 33122107 | PubTator, text mining | PubMed |
| Identification of RUNX1T1 as a potential epigenetic modifier in small-cell lung cancer. | Mol Oncol | 2021 | 33084222 | PubTator, text mining | PubMed |
| Bone health effects of androgen-deprivation therapy and androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer. | Prostate Cancer Prostatic Dis | 2021 | 33028943 | PubTator, text mining | PubMed |
| Clinical, morphologic, and genomic findings in ROS1 fusion Spitz neoplasms. | Mod Pathol | 2021 | 32862201 | PubTator, text mining | PubMed |
| Genetic variants in tooth agenesis-related genes might be also involved in tooth size variations. | Clin Oral Investig | 2021 | 32648061 | PubTator, text mining | PubMed |
| [FGFR-targeted therapy in head and neck carcinomas]. | HNO | 2021 | 32519203 | PubTator, text mining | PubMed |
| Transcriptomic analysis of bisphenol AF on early growth and development of zebrafish (Danio rerio) larvae. | Environ Sci Ecotechnol | 2020 | 36157705 | PubTator, text mining | PubMed |
| From "S" to "O": experimental and theoretical insights into the atmospheric degradation mechanism of dithiophosphinic acids. | RSC Adv | 2020 | 35520876 | PubTator, text mining | PubMed |
| The association between genomic variations and histological grade in hepatocellular carcinoma. | Transl Cancer Res | 2020 | 35117602 | PubTator, text mining | PubMed |
| Switching between mono and doubly reduced odd alternant hydrocarbon: designing a redox catalyst. | Chem Sci | 2020 | 34164073 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2248/papers?page=37